These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 32382582)
21. Assessment of the arterial stiffness in patients with acute ischemic stroke using longitudinal elasticity modulus measurements obtained with Shear Wave Elastography. Li Z; Du L; Wang F; Luo X Med Ultrason; 2016 Jun; 18(2):182-9. PubMed ID: 27239652 [TBL] [Abstract][Full Text] [Related]
22. Molecular and Cellular Mechanisms Driving Cardiovascular Disease in Hutchinson-Gilford Progeria Syndrome: Lessons Learned from Animal Models. Benedicto I; Dorado B; Andrés V Cells; 2021 May; 10(5):. PubMed ID: 34064612 [TBL] [Abstract][Full Text] [Related]
23. Direct reprogramming of human smooth muscle and vascular endothelial cells reveals defects associated with aging and Hutchinson-Gilford progeria syndrome. Bersini S; Schulte R; Huang L; Tsai H; Hetzer MW Elife; 2020 Sep; 9():. PubMed ID: 32896271 [TBL] [Abstract][Full Text] [Related]
24. Hutchinson-Gilford progeria syndrome, cardiovascular disease and oxidative stress. Trigueros-Motos L; Gonzalez JM; Rivera J; Andres V Front Biosci (Schol Ed); 2011 Jun; 3(4):1285-97. PubMed ID: 21622271 [TBL] [Abstract][Full Text] [Related]
25. Echo-Doppler assessment of arterial stiffness in pediatric patients with Kawasaki disease. AlHuzaimi A; Al Mashham Y; Potts JE; De Souza AM; Sandor GG J Am Soc Echocardiogr; 2013 Sep; 26(9):1084-9. PubMed ID: 23800509 [TBL] [Abstract][Full Text] [Related]
26. Mechanisms of angiogenic incompetence in Hutchinson-Gilford progeria via downregulation of endothelial NOS. Gete YG; Koblan LW; Mao X; Trappio M; Mahadik B; Fisher JP; Liu DR; Cao K Aging Cell; 2021 Jul; 20(7):e13388. PubMed ID: 34086398 [TBL] [Abstract][Full Text] [Related]
27. Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria Syndrome. Gordon LB; Kleinman ME; Massaro J; D'Agostino RB; Shappell H; Gerhard-Herman M; Smoot LB; Gordon CM; Cleveland RH; Nazarian A; Snyder BD; Ullrich NJ; Silvera VM; Liang MG; Quinn N; Miller DT; Huh SY; Dowton AA; Littlefield K; Greer MM; Kieran MW Circulation; 2016 Jul; 134(2):114-25. PubMed ID: 27400896 [TBL] [Abstract][Full Text] [Related]
28. Reference Ranges of Left Ventricular Strain Measures by Two-Dimensional Speckle-Tracking Echocardiography in Children: A Systematic Review and Meta-Analysis. Levy PT; Machefsky A; Sanchez AA; Patel MD; Rogal S; Fowler S; Yaeger L; Hardi A; Holland MR; Hamvas A; Singh GK J Am Soc Echocardiogr; 2016 Mar; 29(3):209-225.e6. PubMed ID: 26747685 [TBL] [Abstract][Full Text] [Related]
29. Estimation of vessel age and early diagnose of atherosclerosis in progeria syndrome by using echo-tracking. Várady E; Feher E; Levai A; Battyany I Clin Hemorheol Microcirc; 2010; 44(4):297-301. PubMed ID: 20571244 [TBL] [Abstract][Full Text] [Related]
30. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome. Finley J Med Hypotheses; 2018 Sep; 118():151-162. PubMed ID: 30037605 [TBL] [Abstract][Full Text] [Related]
31. Hutchinson-Gilford progeria is a skeletal dysplasia. Gordon CM; Gordon LB; Snyder BD; Nazarian A; Quinn N; Huh S; Giobbie-Hurder A; Neuberg D; Cleveland R; Kleinman M; Miller DT; Kieran MW J Bone Miner Res; 2011 Jul; 26(7):1670-9. PubMed ID: 21445982 [TBL] [Abstract][Full Text] [Related]
33. Aggrecan expression is substantially and abnormally upregulated in Hutchinson-Gilford Progeria Syndrome dermal fibroblasts. Lemire JM; Patis C; Gordon LB; Sandy JD; Toole BP; Weiss AS Mech Ageing Dev; 2006 Aug; 127(8):660-9. PubMed ID: 16650460 [TBL] [Abstract][Full Text] [Related]
34. Aging in the Cardiovascular System: Lessons from Hutchinson-Gilford Progeria Syndrome. Hamczyk MR; del Campo L; Andrés V Annu Rev Physiol; 2018 Feb; 80():27-48. PubMed ID: 28934587 [TBL] [Abstract][Full Text] [Related]
35. Mechanisms of vascular aging: What can we learn from Hutchinson-Gilford progeria syndrome? Del Campo L; Hamczyk MR; Andrés V; Martínez-González J; Rodríguez C; Clin Investig Arterioscler; 2018; 30(3):120-132. PubMed ID: 29602596 [TBL] [Abstract][Full Text] [Related]
36. Hutchinson-Gilford progeria syndrome complicated with stroke: A report of 2 cases and literature review. Wang J; Yu Q; Ma X; Yuan Z; Mao J Front Pediatr; 2022; 10():1056225. PubMed ID: 36523395 [TBL] [Abstract][Full Text] [Related]
37. Hutchinson-Gilford progeria syndrome: clinical findings in three patients carrying the G608G mutation in LMNA and review of the literature. Mazereeuw-Hautier J; Wilson LC; Mohammed S; Smallwood D; Shackleton S; Atherton DJ; Harper JI Br J Dermatol; 2007 Jun; 156(6):1308-14. PubMed ID: 17459035 [TBL] [Abstract][Full Text] [Related]
38. Impact of arterial stiffening on left ventricular structure. Roman MJ; Ganau A; Saba PS; Pini R; Pickering TG; Devereux RB Hypertension; 2000 Oct; 36(4):489-94. PubMed ID: 11040224 [TBL] [Abstract][Full Text] [Related]
40. Age-related normal range of left ventricular strain and torsion using three-dimensional speckle-tracking echocardiography. Kaku K; Takeuchi M; Tsang W; Takigiku K; Yasukochi S; Patel AR; Mor-Avi V; Lang RM; Otsuji Y J Am Soc Echocardiogr; 2014 Jan; 27(1):55-64. PubMed ID: 24238753 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]